Intellia Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Intellia Therapeutics Inc
TickerNTLA
CIK #0001652130
CUSIP45826J105
SectorLife Sciences - In Vitro & In Vivo Diagnostic Substances
Address130 Brookline Street Suite 201, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2025
[0001652130] 10-K
[0001652130] 10-Q
[0001652130] 3
[0001652130] 4
[0001652130] 5
[0001652130] 8-K
[0001652130] D
[0001652130] SC 13D
[0001652130] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Intellia Therapeutics Inc [2025-05-13] 0.0
BlackRock Inc Intellia Therapeutics Inc [2023-01-25] 8.7
FMR LLC Intellia Therapeutics Inc [2022-02-09] 0.0
Nikko Asset Management Americas Inc Intellia Therapeutics Inc [2019-07-09] 11.29
Sumitomo Mitsui Trust Holdings Inc Intellia Therapeutics Inc [2019-07-09] 11.29
ARK Investment Management LLC Intellia Therapeutics Inc [2019-02-14] 15.67
State Street Corp Intellia Therapeutics Inc [2019-02-13] 5.3
Vanguard Group Inc Intellia Therapeutics Inc [2019-02-11] 6.32
BlackRock Inc Intellia Therapeutics Inc [2019-02-08] 6.6
Caribou Biosciences Inc Intellia Therapeutics Inc [2017-02-28] 0.0
Atlas Venture Fund IX LP Intellia Therapeutics Inc [2017-02-09] 12.3
FMR LLC Intellia Therapeutics Inc [2016-06-10] 0.0
OrbiMed Advisors LLC Intellia Therapeutics Inc [2016-05-20] 7.4
Novartis Institutes for Biomedical Research Inc Intellia Therapeutics Inc [2016-05-11] 15.48
Regeneron Pharmaceuticals Inc Intellia Therapeutics Inc [2016-05-11] 7.7
Form 3/4/5 Filer 2011 - 2025
Intellia Therapeutics, Inc.
Dulac Edward J III
Dube Michael P
Clark Eliana
Goodman Jesse
Keresty Georgia
Goff Brian
Bhanji Muna
Chase William J
Cohen Fred E
Verwiel Frank
Basta James
Leonard John M
Lebwohl David
Schultes Birgit C
Hicks Derek
Sepp-Lorenzino Laura
Goddard Glenn
Crowley John F
Formela Jean Francois
Dorsa Caroline
Rivera Jose E
Schiermeier Andrew
Karsen Perry A
Novartis Institutes for BioMedical Research, Inc.
Novartis AG
Hayes John T
Bell Graeme
Caribou Biosciences, Inc.
Bermingham Nessan
Slaoui Moncef
Atlas Venture Associates IX, L.P.
Atlas Venture Fund IX, L.P.
Atlas Venture Associates IX, LLC
Gordon Carl L
Heifner Nicole
Morrissey David V
Barnes Thomas M.
Temasek Life Sciences Private Ltd
Fullerton Management Pte Ltd
Temasek Holdings (Private) Ltd
TLS Beta Pte. Ltd.
OrbiMed Advisors LLC
OrbiMed Global Healthcare GP LLC
Isaly Samuel D
OrbiMed Capital GP V LLC
Caribou Therapeutics Holdco, LLC
Haurwitz Rachel E.
Baker Bros Advisors LP
Baker Felix
Baker Bros. Advisors (GP) LLC
Baker Julian
Srivastava Sapna
Foresite Capital Management III, LLC
Foresite Capital Fund III, L.P.
Tananbaum James B.
Form 13F Holdings
Firm Period DFND Voting Shares
ARK Investment Management LLC [2025-06-30] SOLE 12,157,190 13,017,876
Vanguard Group Inc [2025-06-30] SOLE 0 10,661,104
BlackRock, Inc. [2025-06-30] SOLE 9,635,645 10,027,175
Morgan Stanley [2025-06-30] DFND 3,569,157 4,116,861
State Street Corp [2025-06-30] DFND 3,721,553 4,039,285
Regeneron Pharmaceuticals Inc [2025-06-30] SOLE 3,702,995 3,702,995
Baker Bros Advisors LP [2025-06-30] SOLE 2,675,674 2,675,674
Nikko Asset Management Americas Inc [2025-06-30] SOLE 2,432,992 2,671,265
Sumitomo Mitsui Trust Group, Inc. [2025-06-30] DFND 2,671,265 2,671,265
Geode Capital Management LLC [2025-06-30] DFND 2,606,222 2,606,222
Two Sigma Investments LP [2025-06-30] SOLE 2,276,574 2,276,574
Two Sigma Advisers LP [2025-06-30] SOLE 2,019,617 2,093,017
Goldman Sachs Group Inc [2025-06-30] DFND 2,074,652 2,079,648
Dimensional Fund Advisors LP [2025-06-30] SOLE 1,720,794 1,801,780
Voloridge Investment Management LLC [2025-06-30] SOLE 1,553,234 1,553,234
Contrarius Group Holdings Ltd [2025-06-30] DFND 1,552,508 1,552,508
FMR LLC [2025-06-30] DFND 1,495,611 1,520,548
Balyasny Asset Management LP [2025-06-30] SOLE 1,311,480 1,311,480
Woodline Partners LP [2025-06-30] SOLE 1,219,068 1,219,068
Susquehanna International Group LLP [2025-06-30] OTR 763,981 1,151,481
Citadel Advisors LLC [2025-06-30] DFND 1,137,881 1,137,881
Trexquant Investment LP [2025-06-30] SOLE 1,127,331 1,127,331
UBS Group AG [2025-06-30] DFND 1,106,731 1,121,582
JPMorgan Chase & Co [2025-06-30] DFND 830,761 940,483
Granahan Investment Management LLC [2025-06-30] SOLE 836,002 913,622
Northern Trust Corp [2025-06-30] DFND 890,738 892,013
Charles Schwab Investment Management Inc [2025-06-30] SOLE 856,549 856,549
Millennium Management LLC [2025-06-30] SOLE 831,006 831,006
D. E. Shaw & Co., Inc. [2025-06-30] DFND 824,727 824,727
Stifel Financial Corp [2025-06-30] DFND 776,218 785,034
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com